DrAIStudio

Pharmacology, Toxicology and Pharmaceutics calls for papers accepting submissions

Current open calls for papers in Pharmacology, Toxicology and Pharmaceutics, with deadlines, publisher links, and Journal Finder ranking signals where matched.

Open Pharmacology, Toxicology and Pharmaceutics CFPs

Development of Novel Treatments for Genitourinary Tumors

Deadline 2026-09-15Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics, in conjunction with Guest Advisor Dr. Alessandro Rizzo , is pleased to announce a new Article Collection dedicated to new and novel immunotherapies targeting genitourinary tumors. Genitourinary tumors encompass a broad range of cancer types within the urinary system and male reproductive system and there is a plethora of novel investigational drugs under current clinical developm…

Generate research ideas Open CFP source Submit

Behavioral and Psychosocial Aspects in the Management and Treatment of Diabetes and Obesity

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Diabetes and obesity remain major challenges for modern societies, not only because of their rising prevalence but also due to the substantial burden they place on people living with these conditions and their families. Although medical care has advanced significantly—with new medications, improved insulin formulations, and modern technologies—clinical outcomes often remain suboptimal. Increasing evidence highlights…

Generate research ideas Open CFP source Submit

Advances in p53 Drug Discovery

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Drug Design, Development and Therapy

Often referred to as the "guardian of the genome", p53 plays an important role in maintaining cellular homeostasis by regulating and orchestrating cell cycle arrest, DNA repair, apoptosis, and senescence. Mutations in the TP53 gene which encodes p53, are found in a broad range of human cancers, leading to loss of its tumor-suppressive functions and contributing to cancer progression and metastasis. In addition, some…

Generate research ideas Open CFP source Submit

Understanding the unique nature of wildfire smoke exposures and the resulting adverse health effects

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Inhalation Toxicology

With the increase in wildfires globally, the concern for understanding the potential health consequences of wildfire smoke is of great interest. Current guidance on mitigating the adverse effects from these exposures has focused on PM 2.5 levels as determined by historic urban air pollution studies. However, wildfire smoke exposures do not fit neatly into the urban air pollution paradigm. In addition to wildfire smo…

Generate research ideas Open CFP source Submit

Biomarker Discovery and Therapeutic Targeting of Oncogenic Signaling and Epigenetic Pathways for Novel Anti-cancer Agents — In memory of Dr. Chang-Deng Hu

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

This Article Collection is dedicated to the memory of Dr. Chang-Deng Hu, who passed away on September 1, 2022, after a brief battle with cholangiocarcinoma. A named professor in the Borch Department of Medicinal Chemistry and Molecular Pharmacology and Institute for Cancer Research at Purdue University, Dr. Hu was internationally recognized for his pioneering contributions to cancer biology, enzyme inhibition, signa…

Generate research ideas Open CFP source Submit

Therapeutic Effect of Cyclodextrins in Diseases

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Pharmaceutical Biology

Cyclodextrins (CDs) are cyclic oligosaccharides made up of various numbers of a-(1,4)-linked glucopyranose subunits, including alpha-cyclodextrin (α-CD; six subunits), beta-cyclodextrin (β-CD; seven subunits), and gamma-cyclodextrin (γ -CD; eight subunits). These cyclodextrins are naturally produced by the enzymatic hydrolysis of starch. To improve some properties (e.g., water solubility), many derivatives of cyclod…

Generate research ideas Open CFP source Submit

CAR T Cell Therapies Beyond Oncology

Deadline 2026-10-15Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to announce a new Article Collection dedicated to the examining how CAR T cell therapy can be used to treat chronic inflammatory and autoimmune disorders. Chimeric antigen receptor (CAR) T cells have proven efficacy as therapies for hematologic malignancies. Now, CAR T cells are showing promise in the treatment of chronic inflammatory and autoimmune conditions. Because…

Generate research ideas Open CFP source Submit

Vaccines at a Crossroads: Precision Vaccinology as a New Paradigm

Deadline 2026-10-16Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Vaccines at a Crossroads: Precision Vaccinology as a New Paradigm" in conjunction with the 5th Biennial International Precision Vaccines Conference. The emergence of precision medicine in the development of safe and effective vaccines to protect against infectious and non-infectious diseases, provides an…

Generate research ideas Open CFP source Submit

Exploring Recent Advances of Nanomedicine in Modulating Tumor Microenvironments and Tissue Engineering

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Drug Delivery

Nanomedicine is reshaping cancer treatment and regenerative medicine through targeted, precise interventions. Recent breakthroughs focus on modulating the tumor microenvironment (TME)—a complex matrix of cells and signals surrounding tumors that influence their growth and resistance to therapies. At the same time, nanotechnology enhances tissue engineering by enabling the creation of biomimetic scaffolds and deliver…

Generate research ideas Open CFP source Submit

Targeted Protein Degradation for Drug Development and Delivery

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Drug Delivery

Targeted protein degradation (TPD) represents a transformative approach in drug discovery, shifting the paradigm from traditional inhibition to selective degradation of disease-causing proteins. Proteolysis targeting chimeras (PROTACs), among other emerging technologies, offer promising avenues to modulate previously "undruggable" targets by harnessing the cell's natural protein degradation machinery. This collectio…

Generate research ideas Open CFP source Submit

Exploring Fragment-Based Approaches in Drug Discovery

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Drug Design, Development and Therapy

With the emergence of fragment-based drug discovery (FBDD), the field of drug discovery has undergone significant changes. Unlike traditional high-throughput screening techniques, FBDD is based on identifying low molecular weight compounds (fragments) with a low affinity to the biological target. These initial fragment hits are then developed into drug-like molecules through a range of techniques, including fragment…

Generate research ideas Open CFP source Submit

Sol Gel Based Hybrid Materials in Drug Delivery and Biotherapeutic Stabilization

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Drug Design, Development and Therapy

The development of advanced drug delivery systems is essential for improving the efficacy and shelf-life of sensitive biomolecules, including proteins, peptides, and nucleic acids. Among emerging technologies, sol gel-derived hybrid materials, particularly silica-based matrices, have gained prominence as versatile platforms for therapeutic stabilization and delivery. These materials offer mild synthesis conditions,…

Generate research ideas Open CFP source Submit

Mass Spectrometry in Medicinal Chemistry and Molecular Discovery

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Mass spectrometry has become a central analytical platform in medicinal chemistry, informing research that spans small molecule discovery, peptide and protein therapeutics, biomolecular mechanism, and translational studies. The ability to measure molecular structures, define interactions, assess chemical stability, and characterise biological mixtures directly has made mass spectrometry a valued tool across early di…

Generate research ideas Open CFP source Submit

Small Molecule Inhibitors for Targeting Cancer

Deadline 2026-10-31Taylor & FrancisIndexed (Active)

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Small molecule inhibitors remain one of the most dynamic and versatile classes of anticancer therapeutics and represent a cornerstone of modern precision oncology. Advances in structure-guided drug design, high-throughput screening, chemical biology, and computational modelling have enabled the rapid discovery of highly potent and selective modulators targeting oncogenic kinases, epigenetic enzymes, metabolic pathwa…

Generate research ideas Open CFP source Submit

Advanced Computational and Statistical Learning Methods for Pharmaceutical Research: Focusing on Reproducibility, Robustness, Integrity, Interpretability and Other Desired Properties

Deadline 2026-11-01Taylor & FrancisIndexed (Active)

Journal: Statistics in Biopharmaceutical Research

Submission Timeline First submission : June 1, 2026 Submission deadline : November 1, 2026 Statistics in Biopharmaceutical Research (SBR) invites submissions for a special issue on computational methods with desired properties for biopharmaceutical applications. The biopharmaceutical industry faces increasingly complex challenges, such as leveraging real-world data (RWD) from electronic health records and registries…

Generate research ideas Open CFP source Submit

Deciphering Immunotherapy Resistance: Targets, Mechanisms, and Therapeutic Innovations

Deadline 2026-11-16Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to announce a new Article Collection dedicated to understanding mechanisms and developing new therapeutics to combat immunotherapy resistance. Immunotherapy has transformed the landscape of modern medicine by harnessing the immune system to prevent or treat diseases. While therapeutic vaccines and immune checkpoint modulators have demonstrated remarkable success, their…

Generate research ideas Open CFP source Submit

Human Microbiome and Vaccine Efficacy

Deadline 2026-11-30Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Human Microbiome and Vaccine Efficacy". This Article Collection focuses on examining the influence of the human microbiome on vaccine safety and efficacy. Recent research indicates that the composition of microflora in diverse human tissues is influenced by factors including age, ethnicity, environment, l…

Generate research ideas Open CFP source Submit

Computational Toxicology for Exposure Science and Risk Assessment: From Mechanistic Modeling to Regulatory Translation

Deadline 2026-11-30Taylor & FrancisIndexed (Active)

Journal: Toxicology Communications

This Article Collection aims to showcase cutting-edge research at the intersection of computational toxicology, exposure assessment, and regulatory decision-making. Emphasis is placed on methods that bridge molecular-level information with real-world exposure data to support hazard identification, dose–response assessment, and risk characterization. Recent developments in physiologically based kinetic (PBK) modeling…

Generate research ideas Open CFP source Submit

Immunization and Disasters

Deadline 2026-12-01Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Immunization and Disasters". Disasters are a major challenge for infectious disease control and elimination. Disruption of food systems, degradation of housing, water supply, and waste management, and reduced functioning of transportation systems and public health institutions during and following a disas…

Generate research ideas Open CFP source Submit

Real World Evidence for the Pharmacological Treatment of Diabetes: From Clinical Trials to Routine Practice

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Diabetes mellitus represents one of the most pressing global health challenges of the 21st century, affecting over 500 million adults worldwide. The pharmacological landscape for diabetes has expanded rapidly, with the introduction of incretin-based therapies, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and dual-acting agents alongside established glucose-lowering drug classes. While randomized controlled tri…

Generate research ideas Open CFP source Submit

Chikungunya Virus: Advances in Understanding a Re-emerging Arboviral Threat

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Emerging Microbes & Infections

Since its first documented outbreak in Tanzania in 1952, Chikungunya virus has undergone dramatic geographic expansion, with 119 countries and territories reporting local transmission as of 2024. According to the Pan American Health Organization, 431,223 confirmed cases with 243 deaths were reported in 2024. In the first 9 months of 2025, 445,271 suspected and confirmed Chikungunya infected cases and 155 deaths had…

Generate research ideas Open CFP source Submit

Nipah Virus in Focus

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Emerging Microbes & Infections

Nipah virus (NiV), a zoonotic disease, first emerged in Malaysia in 1998. Since then, cases of Nipah virus infection have been reported in Bangladesh, India, Malaysia, the Philippines and Singapore. As the epidemiology of Nipah virus unfolds, recurring outbreaks highlight the unpredictable nature of emerging infectious disease. The case fatality rate of Nipah virus outbreaks has ranged from 40% to 75%, and with no l…

Generate research ideas Open CFP source Submit

Advances and Implementation Challenges in Vaccine Confidence, Access, and Immunization Programs in LMICs of the Global South

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Advances and Implementation Challenges in Vaccine Confidence, Access, and Immunization Programs in LMICs of the Global South". Vaccination programs continue to be one of the most impactful public health interventions, yet many countries in the Global South face persistent and emerging barriers that threat…

Generate research ideas Open CFP source Submit

A Special Collection Dedicated to the Memory of Professor Minyong Li (李敏勇): Recent Progress in Drug Discovery, Chemical Biology, and Optical Tools

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

In honour of Professor Minyong Li, who passed away at a young age of 49, we seek contributions to this Article Collection. As is well-recognized, Professor Li made very significant contributions to drug design, drug delivery, development of chemical biology tools, and fluorescent sensing. Therefore, we seek contributions in any of these areas. In seeking contributions in drug design, drug delivery, development of ch…

Generate research ideas Open CFP source Submit

Circulating Biomarkers and AI in Therapeutics and Clinical Risk Management: From Molecular Signals to Precision Medicine

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Therapeutics and Clinical Risk Management

Circulating biomarkers are increasingly reshaping the landscape of modern medicine by enabling minimally invasive, dynamic assessment of disease processes across diverse clinical settings. Among these, cell-free DNA (cfDNA) has emerged as a particularly versatile analyte, offering insights into tissue damage, clonal evolution, and therapeutic response in real time. Beyond its established role in oncology, cfDNA and…

Generate research ideas Open CFP source Submit

Current and Emerging Strategies in the Management of Cardiac Arrhythmias

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Therapeutics and Clinical Risk Management

Cardiac arrhythmias remain a major cause of morbidity, mortality, hospitalization, and impaired quality of life worldwide. They encompass a broad and increasingly complex spectrum of disorders, ranging from atrial fibrillation and supraventricular tachycardias to ventricular arrhythmias, conduction disease, and inherited arrhythmic syndromes. Over the past few years, the field has evolved rapidly, driven by major ad…

Generate research ideas Open CFP source Submit

Novel Biomarkers and Molecular Biology of Solid Tumors

Deadline 2027-01-31Taylor & FrancisIndexed (Active)

Journal: Therapeutics and Clinical Risk Management

Solid tumors are biologically heterogeneous diseases shaped by dynamic interactions among genomic alterations, epigenetic states, transcriptional programs, the tumor microenvironment, and host factors. As a result, there is growing interest in biomarkers that can capture tumor behavior more accurately than conventional clinicopathologic variables alone. This Article Collection will focus on emerging biomarkers and m…

Generate research ideas Open CFP source Submit

Advancing Immunization in China: Bridging Policy, Evidence, and Practice

Deadline 2027-02-01Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Advancing Immunization in China: Bridging Policy, Evidence, and Practice". Over the past several decades, China’s National Immunization Program (NIP) has achieved remarkable and far-reaching success, driving the incidence of numerous vaccine-preventable diseases (VPDs) to historic lows and substantially r…

Generate research ideas Open CFP source Submit

Migrastatic Agents, Metastasis, and Mitochondrial Metabolism: Emerging Strategies for Cancer Drug Discovery

Deadline 2027-02-28FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Cancer remains one of the leading causes of death worldwide. Despite substantial progress in developing effective therapies over the past century, it remains...

Generate research ideas Open CFP source Submit

Migrastatic Agents, Metastasis, and Mitochondrial Metabolism: Emerging Strategies for Cancer Drug Discovery

Deadline 2027-02-28FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Cancer remains one of the leading causes of death worldwide. Despite substantial progress in developing effective therapies over the past century, it remains...

Generate research ideas Open CFP source Submit

Environmental Determinants of Obesity and Diabetes: Endocrine Disruptors, Pollutants, and Metabolic Risk

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

The global rise in obesity and diabetes has traditionally been attributed to lifestyle factors such as diet and physical inactivity; however, accumulating evidence highlights the critical contribution of environmental determinants to metabolic disease. Among these, endocrine-disrupting chemicals (EDCs) and environmental pollutants have emerged as key drivers of metabolic dysregulation. Widely present in air, water,…

Generate research ideas Open CFP source Submit

Global Trends in Type 1 and Severe Insulin Sufficient Diabetes: Incidence, Diagnosis and Management

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Recent years have seen a change in the diagnostic classification scheme for type 1 diabetes, such that persons with severe insulin deficiency and presentation with diabetic ketoacidosis at diagnosis, but in the absence of classic type 1 diabetes autoantibodies, are now classified as having type 2 diabetes rather than type 1 diabetes. How this may influence the treatment, or change the treatment, of persons with diab…

Generate research ideas Open CFP source Submit

Integrating One Health in Infectious Disease Prevention and Control

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Infection and Drug Resistance

It is increasingly recognized that the management of infectious diseases can be improved through intersectoral or interdisciplinary collaborations. One of the most prominent examples is the development of the rabies vaccine, which first demonstrated efficacy in dogs and was later adapted as post-exposure prophylaxis in humans. In 1964, Calvin Schwabe, a distinguished veterinarian and epidemiologist, coined the term…

Generate research ideas Open CFP source Submit

Botanical Safety Consortium: Collaborative Approaches to Botanical Safety and Decision-Making

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Pharmaceutical Biology

Article submission in this article collection is "by invitation only". The Botanical Safety Consortium (BSC) was established in 2019 as a public–private partnership among the U.S. FDA, NIEHS, and HESI to address critical gaps in evaluating the safety of botanical products. Botanicals, including plant-, algae-, and fungi-derived ingredients, pose unique challenges for toxicological assessment because their natural co…

Generate research ideas Open CFP source Submit

Kratom, Alkaloid-Concentrated Products, and Emerging Derivatives: Chemistry, Safety, Market Evolution, and Public Health Implications

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Pharmaceutical Biology

Kratom ( Mitragyna speciosa Korth.) is a tropical tree native to Southeast Asia whose leaves contain indole and oxindole alkaloids with pharmacological activity. In contemporary commerce, the term “kratom” may refer to products that differ substantially in botanical composition, processing, alkaloid profile, and dose. These include dried leaf preparations, commercial powders, extracts, concentrated alkaloid products…

Generate research ideas Open CFP source Submit

Bioactive Natural Products from Marine and Terrestrial Sources: Isolation, Structural Diversity, and Biological Activity

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Natural Products

Marine and terrestrial organisms—including soft corals, marine fungi, and plants—remain rich sources of structurally diverse secondary metabolites with signi...

Generate research ideas Open CFP source Submit

Bioactive Natural Products from Marine and Terrestrial Sources: Isolation, Structural Diversity, and Biological Activity

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Natural Products

Marine and terrestrial organisms—including soft corals, marine fungi, and plants—remain rich sources of structurally diverse secondary metabolites with signi...

Generate research ideas Open CFP source Submit

Aquaculture as an Antibiotic Resistance Hotspot: Environmental Dissemination, One Health Impacts, and Novel Mitigation Strategies

Deadline 2027-03-06FrontiersIndexed (Active)

Journal: Frontiers in Antibiotics

The rapid expansion and intensification of global aquaculture have established it as a cornerstone of food security and economic growth. However, this growth...

Generate research ideas Open CFP source Submit

Aquaculture as an Antibiotic Resistance Hotspot: Environmental Dissemination, One Health Impacts, and Novel Mitigation Strategies

Deadline 2027-03-06FrontiersIndexed (Active)

Journal: Frontiers in Antibiotics

The rapid expansion and intensification of global aquaculture have established it as a cornerstone of food security and economic growth. However, this growth...

Generate research ideas Open CFP source Submit

Advances in Personalized Management of Patients with Airways Diseases

Deadline 2027-03-09FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Asthma and COPD remain leading causes of morbidity worldwide, and both are increasingly recognized as heterogeneous conditions encompassing multiple inflamma...

Generate research ideas Open CFP source Submit

Advances in Personalized Management of Patients with Airways Diseases

Deadline 2027-03-09FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Asthma and COPD remain leading causes of morbidity worldwide, and both are increasingly recognized as heterogeneous conditions encompassing multiple inflamma...

Generate research ideas Open CFP source Submit

Smart Materials and Devices for Stimuli-Responsive Drug Delivery

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Smart materials and responsive drug delivery devices represent an important evolution in biomedical engineering. Advances in polymers, hydrogels, nanocarrier...

Generate research ideas Open CFP source Submit

Smart Materials and Devices for Stimuli-Responsive Drug Delivery

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Smart materials and responsive drug delivery devices represent an important evolution in biomedical engineering. Advances in polymers, hydrogels, nanocarrier...

Generate research ideas Open CFP source Submit

Antimicrobial and Antiparasitic Drug Discovery: Experimental Pharmacology, Computational and AI/ML Approaches, and Translational Strategies

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Antimicrobial resistance is one of the defining health threats of our time. Drug-resistant bacteria, fungi, and parasites now undermine treatments that once ...

Generate research ideas Open CFP source Submit

Computational Pharmacogenomics: Artificial Intelligence and Machine Learning for Variant Effect Prediction and Clinical Translation

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Over the past two decades, pharmacogenomics has shifted from common, coding variants in single populations toward genome-wide, cross-population analyses that...

Generate research ideas Open CFP source Submit

Computational Pharmacogenomics: Artificial Intelligence and Machine Learning for Variant Effect Prediction and Clinical Translation

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Over the past two decades, pharmacogenomics has shifted from common, coding variants in single populations toward genome-wide, cross-population analyses that...

Generate research ideas Open CFP source Submit

Fragment-Based Drug Discovery: Innovations, Challenges, and Translational Opportunities in Experimental Pharmacology

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Fragment-based drug discovery (FBDD) has rapidly evolved into a powerful approach for identifying and optimizing novel therapeutic agents. By using small, lo...

Generate research ideas Open CFP source Submit

Fragment-Based Drug Discovery: Innovations, Challenges, and Translational Opportunities in Experimental Pharmacology

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Fragment-based drug discovery (FBDD) has rapidly evolved into a powerful approach for identifying and optimizing novel therapeutic agents. By using small, lo...

Generate research ideas Open CFP source Submit

Institutional Implementation of Pharmacogenomics: Health Systems Policies, Barriers, and Best Practice Models

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Pharmacogenomics (PGx) offers a clinically actionable route to precision prescribing: by tailoring drug selection and dosing to an individual’s genetic profi...

Generate research ideas Open CFP source Submit

Institutional Implementation of Pharmacogenomics: Health Systems Policies, Barriers, and Best Practice Models

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Pharmacogenomics (PGx) offers a clinically actionable route to precision prescribing: by tailoring drug selection and dosing to an individual’s genetic profi...

Generate research ideas Open CFP source Submit

Pharmacogenomic Variability in Drug Metabolism: From Nuclear Receptors to Clinical Enzyme Regulation

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The regulation of drug-metabolizing enzymes (DMEs) is governed by nuclear receptors (NRs) — including PXR, CAR, AhR, FXR, and PPARα — that sense xenobiotic a...

Generate research ideas Open CFP source Submit

Pharmacogenomic Variability in Drug Metabolism: From Nuclear Receptors to Clinical Enzyme Regulation

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The regulation of drug-metabolizing enzymes (DMEs) is governed by nuclear receptors (NRs) — including PXR, CAR, AhR, FXR, and PPARα — that sense xenobiotic a...

Generate research ideas Open CFP source Submit

Protein Structure, Dynamics, and Function in Modern Drug Discovery

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Understanding how proteins fold, move, and interact with ligands sits at the heart of rational drug discovery. Advances in structural biology, including cryo...

Generate research ideas Open CFP source Submit

Protein Structure, Dynamics, and Function in Modern Drug Discovery

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Understanding how proteins fold, move, and interact with ligands sits at the heart of rational drug discovery. Advances in structural biology, including cryo...

Generate research ideas Open CFP source Submit

Real-World Safety Outcomes and Policy Responses to Adverse Drug Reactions

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Adverse drug reactions (ADRs) remain a major, and often preventable, source of patient harm even after drugs have received marketing authorization. In line w...

Generate research ideas Open CFP source Submit

Real-World Safety Outcomes and Policy Responses to Adverse Drug Reactions

Deadline 2027-03-12FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Adverse drug reactions (ADRs) remain a major, and often preventable, source of patient harm even after drugs have received marketing authorization. In line w...

Generate research ideas Open CFP source Submit

Artificial Intelligence in Drug Metabolism and Transport: From Multi-Omics Insights to Clinical and Pharmacological Validation

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Artificial intelligence (AI) is transforming pharmaceutical research by enabling the integration and interpretation of increasingly complex biological and ph...

Generate research ideas Open CFP source Submit

Artificial Intelligence in Drug Metabolism and Transport: From Multi-Omics Insights to Clinical and Pharmacological Validation

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Artificial intelligence (AI) is transforming pharmaceutical research by enabling the integration and interpretation of increasingly complex biological and ph...

Generate research ideas Open CFP source Submit

Nanoformulation Strategies to Overcome Multi-Drug Resistance in Cancer: From Pharmacological Characterization to Preclinical Translation

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Multi-drug resistance (MDR) remains the most formidable pharmacological barrier to effective cancer chemotherapy, accounting for treatment failure in the maj...

Generate research ideas Open CFP source Submit

Nanoformulation Strategies to Overcome Multi-Drug Resistance in Cancer: From Pharmacological Characterization to Preclinical Translation

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Multi-drug resistance (MDR) remains the most formidable pharmacological barrier to effective cancer chemotherapy, accounting for treatment failure in the maj...

Generate research ideas Open CFP source Submit

Volume II: Integrated PK/PD and Drug Metabolism Approaches in Drug Development and Evaluation

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Building on the success of Integrated PK/PD and Drug Metabolism Approaches in Drug Development and Evaluation, this Volume II continues to explore the essent...

Generate research ideas Open CFP source Submit

Shifting perspectives: In vitro, in vivo, transgenic and disease models in inhalation toxicology

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Inhalation toxicology is undergoing a profound paradigm shift. Traditional in vivo testing is increasingly complemented, and in some areas replaced, by advan...

Generate research ideas Open CFP source Submit

Immunogenic Cell Death: From Mechanistic Insights to Pharmacological Intervention and Drug Discovery

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Immunogenic cell death (ICD) is a form of regulated cell death that not only eliminates stressed, damaged, or malignant cells but also actively alerts and en...

Generate research ideas Open CFP source Submit

Immunogenic Cell Death: From Mechanistic Insights to Pharmacological Intervention and Drug Discovery

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Immunogenic cell death (ICD) is a form of regulated cell death that not only eliminates stressed, damaged, or malignant cells but also actively alerts and en...

Generate research ideas Open CFP source Submit

Emerging Applications and Approaches Using Fish Cell Lines

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Fish cell lines have emerged as indispensable tools in modern science, serving as the foundation for versatile New Approach Methodologies (NAMs). These in vi...

Generate research ideas Open CFP source Submit

Emerging Applications and Approaches Using Fish Cell Lines

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Fish cell lines have emerged as indispensable tools in modern science, serving as the foundation for versatile New Approach Methodologies (NAMs). These in vi...

Generate research ideas Open CFP source Submit

Molecular Mechanisms in Biology: Integrating Computational Modeling, Artificial Intelligence, and Experimental Approaches

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Chemical Biology

Understanding the molecular mechanisms that govern biological function requires an interdisciplinary approach that connects molecular-level insights with exp...

Generate research ideas Open CFP source Submit

Molecular Mechanisms in Biology: Integrating Computational Modeling, Artificial Intelligence, and Experimental Approaches

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Chemical Biology

Understanding the molecular mechanisms that govern biological function requires an interdisciplinary approach that connects molecular-level insights with exp...

Generate research ideas Open CFP source Submit

Adaptive Liver-Targeted Drug Delivery in Hepatic Disease and Impairment

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Pharmacodynamics and pharmacokinetics of many therapeutic agents are altered in hepatic diseases and hepatic impairment. The liver is an important organ for ...

Generate research ideas Open CFP source Submit

Adaptive Liver-Targeted Drug Delivery in Hepatic Disease and Impairment

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Pharmacodynamics and pharmacokinetics of many therapeutic agents are altered in hepatic diseases and hepatic impairment. The liver is an important organ for ...

Generate research ideas Open CFP source Submit

Emerging Horizons of Metformin: Exploring Recent Advances and Addressing Challenges in Research and Clinical Utilization, Volume II

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Metformin remains one of the most widely prescribed oral biguanides for type 2 diabetes, yet its reach now extends far beyond glucose control. Research conti...

Generate research ideas Open CFP source Submit

Emerging Horizons of Metformin: Exploring Recent Advances and Addressing Challenges in Research and Clinical Utilization, Volume II

Deadline 2027-03-15FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Metformin remains one of the most widely prescribed oral biguanides for type 2 diabetes, yet its reach now extends far beyond glucose control. Research conti...

Generate research ideas Open CFP source Submit

Targeting Metabolic Reprogramming in Cancer: From Multi-Omics Signatures to Functional Pharmacology

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Cancer cells undergo extensive metabolic reprogramming to sustain proliferation, survival, invasion, and resistance to therapy. Beyond aerobic glycolysis, tu...

Generate research ideas Open CFP source Submit

Targeting Metabolic Reprogramming in Cancer: From Multi-Omics Signatures to Functional Pharmacology

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Cancer cells undergo extensive metabolic reprogramming to sustain proliferation, survival, invasion, and resistance to therapy. Beyond aerobic glycolysis, tu...

Generate research ideas Open CFP source Submit

Anatomically Targeted Antifungal Drug Delivery and Combination Therapies

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Fungal infections caused by clinically relevant pathogens have become a growing global health concern, while effective treatment remains limited by the diffi...

Generate research ideas Open CFP source Submit

Anatomically Targeted Antifungal Drug Delivery and Combination Therapies

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Fungal infections caused by clinically relevant pathogens have become a growing global health concern, while effective treatment remains limited by the diffi...

Generate research ideas Open CFP source Submit

Bioinspired and Biomimetic Drug Delivery Strategies to Overcome Resistance in Solid Tumors

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Nanotechnology has expanded the therapeutic landscape through controlled release, targeted accumulation, prolonged circulation, and improved therapeutic effi...

Generate research ideas Open CFP source Submit

Bioinspired and Biomimetic Drug Delivery Strategies to Overcome Resistance in Solid Tumors

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Nanotechnology has expanded the therapeutic landscape through controlled release, targeted accumulation, prolonged circulation, and improved therapeutic effi...

Generate research ideas Open CFP source Submit

Computational Modeling in Toxicology: NAMs-based Artificial Intelligence, Mechanistic in Silico Approaches, and Software Platforms

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Computational toxicology has evolved from traditional quantitative structure–activity relationship (QSAR) models to sophisticated artificial intelligence (AI...

Generate research ideas Open CFP source Submit

Computational Modeling in Toxicology: NAMs-based Artificial Intelligence, Mechanistic in Silico Approaches, and Software Platforms

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Computational toxicology has evolved from traditional quantitative structure–activity relationship (QSAR) models to sophisticated artificial intelligence (AI...

Generate research ideas Open CFP source Submit

Early warning and prioritization of contaminants of emerging concern for risk assessment

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Contaminants of emerging concern (CECs), including persistent and bioaccumulative substances (e.g., PFAS), micro/nanoplastics, pharmaceuticals, and their env...

Generate research ideas Open CFP source Submit

Early warning and prioritization of contaminants of emerging concern for risk assessment

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Contaminants of emerging concern (CECs), including persistent and bioaccumulative substances (e.g., PFAS), micro/nanoplastics, pharmaceuticals, and their env...

Generate research ideas Open CFP source Submit

Physicochemical and In Silico ADME Profiling of Gut Microbiota-Derived Metabolites: Bridging Computational Prediction and Experimental Validation

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The gut microbiota generates hundreds of structurally distinct bioactive metabolites whose physicochemical properties govern how they behave once they reach ...

Generate research ideas Open CFP source Submit

Physicochemical and In Silico ADME Profiling of Gut Microbiota-Derived Metabolites: Bridging Computational Prediction and Experimental Validation

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The gut microbiota generates hundreds of structurally distinct bioactive metabolites whose physicochemical properties govern how they behave once they reach ...

Generate research ideas Open CFP source Submit

Mixtures and combined exposures in environmental toxicology

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Environmental toxicology increasingly recognizes that organisms are rarely exposed to a single pollutant in isolation. Pesticides, heavy metals, pharmaceutic...

Generate research ideas Open CFP source Submit

Mixtures and combined exposures in environmental toxicology

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Environmental toxicology increasingly recognizes that organisms are rarely exposed to a single pollutant in isolation. Pesticides, heavy metals, pharmaceutic...

Generate research ideas Open CFP source Submit

Real-World Economic Evaluation of Advanced Therapy Medicinal Products After Market Access

Deadline 2027-03-22FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Advanced Therapy Medicinal Products (ATMPs), including gene therapies, cell-based therapies and tissue-engineered products, are transforming the therapeutic ...

Generate research ideas Open CFP source Submit

Real-World Economic Evaluation of Advanced Therapy Medicinal Products After Market Access

Deadline 2027-03-22FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Advanced Therapy Medicinal Products (ATMPs), including gene therapies, cell-based therapies and tissue-engineered products, are transforming the therapeutic ...

Generate research ideas Open CFP source Submit

Quantum Chemistry-Guided Design of Nitrogen-Containing Heterocycles as Anticancer Agents: From Reactivity Descriptors to Biological Validation

Deadline 2027-03-26FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Nitrogen-containing heterocycles, including pyrazoles, pyrimidines, isoxazoles, thiazoles, and naphthyridines, constitute the dominant structural class among...

Generate research ideas Open CFP source Submit

Quantum Chemistry-Guided Design of Nitrogen-Containing Heterocycles as Anticancer Agents: From Reactivity Descriptors to Biological Validation

Deadline 2027-03-26FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Nitrogen-containing heterocycles, including pyrazoles, pyrimidines, isoxazoles, thiazoles, and naphthyridines, constitute the dominant structural class among...

Generate research ideas Open CFP source Submit

Advanced Drug Delivery for Special Patient Populations: From Physiological Barriers to Model-Informed Clinical Translation

Deadline 2027-03-29FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Special patient populations - including neonates and infants, children, pregnant and lactating women, older adults, and patients with organ impairment, criti...

Generate research ideas Open CFP source Submit

Advanced Drug Delivery for Special Patient Populations: From Physiological Barriers to Model-Informed Clinical Translation

Deadline 2027-03-29FrontiersIndexed (Active)

Journal: Frontiers in Drug Delivery

Special patient populations - including neonates and infants, children, pregnant and lactating women, older adults, and patients with organ impairment, criti...

Generate research ideas Open CFP source Submit

The Safety Assessment of Novel Foods and New Nutrient Sources: vol. II

Deadline 2027-03-30FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Novel Foods (NF) are foods derived from unconventional sources such as microorganisms, fungi, plants, insects, or animals, produced through innovative proces...

Generate research ideas Open CFP source Submit

The Safety Assessment of Novel Foods and New Nutrient Sources: vol. II

Deadline 2027-03-30FrontiersIndexed (Active)

Journal: Frontiers in Toxicology

Novel Foods (NF) are foods derived from unconventional sources such as microorganisms, fungi, plants, insects, or animals, produced through innovative proces...

Generate research ideas Open CFP source Submit

Drug Metabolism, Pharmacokinetics, and Bioanalytical Strategies for Small Molecules and Oligonucleotide Therapeutics

Deadline 2027-03-31FrontiersIndexed (Active)

Journal: Frontiers in Drug Discovery

Drug metabolism and pharmacokinetics (DMPK) research forms a cornerstone of modern drug discovery and development. Traditionally, small molecules and monoclo...

Generate research ideas Open CFP source Submit

Drug Metabolism, Pharmacokinetics, and Bioanalytical Strategies for Small Molecules and Oligonucleotide Therapeutics

Deadline 2027-03-31FrontiersIndexed (Active)

Journal: Frontiers in Drug Discovery

Drug metabolism and pharmacokinetics (DMPK) research forms a cornerstone of modern drug discovery and development. Traditionally, small molecules and monoclo...

Generate research ideas Open CFP source Submit

Patient Preferences and Long-term Adherence in Breast and Prostate Cancer: Navigating the Challenges of Survivorship and Chronic Treatment

Deadline 2027-03-31Taylor & FrancisIndexed (Active)

Journal: Patient Preference and Adherence

Breast and prostate cancers currently rank among the most frequent malignancies worldwide. Although significant improvements in early detection and targeted therapies have remarkably extended survival rates, these advancements have also transformed many oncological cases into long-term chronic conditions. The ultimate success of these treatments relies heavily on the ability of the patient to adhere to complex and m…

Generate research ideas Open CFP source Submit

Shared Decision-Making in the Management of Urolithiasis

Deadline 2027-03-31Taylor & FrancisIndexed (Active)

Journal: Patient Preference and Adherence

Urolithiasis affects approximately 10% of the global population, with recurrence rates exceeding 50% within five years despite effective medical and surgical interventions. While technological advances have improved stone treatment, long-term success depends heavily on patient adherence to preventive strategies, including dietary modifications, fluid intake and pharmacological regimens. Adherence, however, remains s…

Generate research ideas Open CFP source Submit

Neurological Adverse Drug Reactions and Clinical Risk

Deadline 2027-03-31Taylor & FrancisIndexed (Active)

Journal: Therapeutics and Clinical Risk Management

Neurological adverse drug reactions (ADRs) represent a broad group of drug-related effects involving the central and peripheral nervous systems. These reactions range from symptoms such as headache, dizziness, and somnolence to more severe manifestations, including cognitive impairment, seizures, and peripheral neuropathy. As pharmacotherapy continues to expand across multiple therapeutic areas, the burden of neurol…

Generate research ideas Open CFP source Submit

Vaccines and Immunotherapy for Epstein Barr Virus, Cytomegalovirus and Related Human Herpesviruses

Deadline 2027-04-01Taylor & FrancisIndexed (Active)

Journal: Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Vaccines and Immunotherapy for Epstein Barr Virus, Cytomegalovirus and Related Human Herpesviruses". Human herpesviruses establish lifelong persistence, undergo periodic reactivation, and cause a wide spectrum of diseases across the lifespan, ranging from asymptomatic infection to congenital disease, infe…

Generate research ideas Open CFP source Submit

Probiotics and Gut Health: Pharmacology of Microbiota Modulation, Mucosal Protection, and Immune Homeostasis

Deadline 2027-04-02FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The gut microbiota plays a critical role in maintaining intestinal homeostasis, including epithelial barrier integrity, mucosal immunity, microbial metabolis...

Generate research ideas Open CFP source Submit

Probiotics and Gut Health: Pharmacology of Microbiota Modulation, Mucosal Protection, and Immune Homeostasis

Deadline 2027-04-02FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The gut microbiota plays a critical role in maintaining intestinal homeostasis, including epithelial barrier integrity, mucosal immunity, microbial metabolis...

Generate research ideas Open CFP source Submit

Innovative Wastewater-Based Epidemiology: Revolutionizing Infectious Disease Monitoring

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Antibiotics

This Research Topic provides a platform for exploring cutting-edge methodologies and technologies in wastewater-based epidemiology (WBE), a pivotal tool for ...

Generate research ideas Open CFP source Submit

Innovative Wastewater-Based Epidemiology: Revolutionizing Infectious Disease Monitoring

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Antibiotics

This Research Topic provides a platform for exploring cutting-edge methodologies and technologies in wastewater-based epidemiology (WBE), a pivotal tool for ...

Generate research ideas Open CFP source Submit

Engineering Extracellular Communication: Glycan Interfaces, Extracellular Vesicles and Soluble Mediators for Integrative and Regenerative Pharmacology

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The secretome is more and more recognized as a dynamic communication system regulating tissue homeostasis, immune responses and regeneration. It comprises tw...

Generate research ideas Open CFP source Submit

Engineering Extracellular Communication: Glycan Interfaces, Extracellular Vesicles and Soluble Mediators for Integrative and Regenerative Pharmacology

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The secretome is more and more recognized as a dynamic communication system regulating tissue homeostasis, immune responses and regeneration. It comprises tw...

Generate research ideas Open CFP source Submit

Integrating Artificial Intelligence, Multi-Omics, and Nanomedicine to Target the Disease Immune Microenvironment

Deadline 2027-04-19FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The immune microenvironment plays a critical role in the progression and therapeutic resistance of a broad spectrum of diseases, most notably in cancers (suc...

Generate research ideas Open CFP source Submit

Integrating Artificial Intelligence, Multi-Omics, and Nanomedicine to Target the Disease Immune Microenvironment

Deadline 2027-04-19FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The immune microenvironment plays a critical role in the progression and therapeutic resistance of a broad spectrum of diseases, most notably in cancers (suc...

Generate research ideas Open CFP source Submit

Targeting Anion Channels and Associated Epithelial Ion Channels in Health and Disease: TMEM16/Anoctamins, ENaC, VRAC, and Beyond

Deadline 2027-04-26FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

The TMEM16/anoctamin family, including ANO1, ANO2, ANO6, and ANO10, is increasingly recognized as a pharmacologically tractable class of proteins with calciu...

Generate research ideas Open CFP source Submit

Structure-Dependent Toxicological Profiles of PFAS: Mechanistic Determinants, Predictive Models, and Organ-Specific Biomarkers

Deadline 2027-04-30FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Per- and polyfluoroalkyl substances (PFAS) comprise a structurally diverse class of thousands of compounds, sharing a persistent carbon-fluorine backbone but...

Generate research ideas Open CFP source Submit

Structure-Dependent Toxicological Profiles of PFAS: Mechanistic Determinants, Predictive Models, and Organ-Specific Biomarkers

Deadline 2027-04-30FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Per- and polyfluoroalkyl substances (PFAS) comprise a structurally diverse class of thousands of compounds, sharing a persistent carbon-fluorine backbone but...

Generate research ideas Open CFP source Submit

Targeting Neuroinflammation in Spinal Cord Injury: From Inflammatory Mechanisms to Pharmacological Interventions

Deadline 2027-04-30FrontiersIndexed (Active)

Journal: Frontiers in Pharmacology

Spinal cord injury (SCI) triggers a devastating secondary neuroinflammatory cascade—driven by microglial activation, immune infiltration, and sustained pro-i...

Generate research ideas Open CFP source Submit

Use CFP Idea Lab to turn a selected call into research questions, theory angles, methods and a submission timeline.